These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8134904)

  • 21. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
    Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet adhesion to collagen-coated wells: analysis of this complex process and a comparison with the adhesion to matrigel-coated wells.
    Moroi M; Okuma M; Jung SM
    Biochim Biophys Acta; 1992 Oct; 1137(1):1-9. PubMed ID: 1390897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new platelet receptor specific to type III collagen. Type III collagen-binding protein.
    Monnet E; Fauvel-Lafève F
    J Biol Chem; 2000 Apr; 275(15):10912-7. PubMed ID: 10753889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and functional interaction between cell-surface calreticulin and the collagen receptors integrin alpha2beta1 and glycoprotein VI in human platelets.
    Elton CM; Smethurst PA; Eggleton P; Farndale RW
    Thromb Haemost; 2002 Oct; 88(4):648-54. PubMed ID: 12362238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhagin.
    Kamiguti AS; Hay CR; Zuzel M
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):635-41. PubMed ID: 8973578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet receptors for collagen.
    Moroi M; Jung SM
    Thromb Haemost; 1997 Jul; 78(1):439-44. PubMed ID: 9198193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of phosphoprotein phosphatase 1 in collagen-platelet interaction.
    Chiang TM; Kang ES; Kang AH
    Thromb Res; 1996 Dec; 84(6):399-409. PubMed ID: 8987161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of protein phosphatases 1 and 2A in collagen-platelet interaction.
    Chiang TM
    Arch Biochem Biophys; 1993 Apr; 302(1):56-63. PubMed ID: 8385905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan.
    Jiang P; Loyau S; Tchitchinadze M; Ropers J; Jondeau G; Jandrot-Perrus M
    PLoS One; 2015; 10(6):e0128744. PubMed ID: 26052700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthetic nonapeptide derived from the sequence of a platelet type I collagen receptor inhibits type I collagen-mediated platelet aggregation.
    Chiang TM
    Am J Med Sci; 2000 Dec; 320(6):362-7. PubMed ID: 11149547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies against human platelet membrane glycoprotein IIIa and collagen-induced platelet activation.
    Kawashima H; Tomaru A; Yamamoto K; Tsuji T; Osawa T
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):397-403. PubMed ID: 2743483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ; Huang TF
    Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptides derived from platelet non-integrin collagen-receptors or types I and III collagen inhibit collagen-platelet interaction.
    Chiang TM; Zhu J; Woo-Rasberry V
    Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):71-5. PubMed ID: 17346130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
    Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promotion of human platelet adhesion and aggregation by a synthetic, triple-helical "mini-collagen".
    Rao GH; Fields CG; White JG; Fields GB
    J Biol Chem; 1994 May; 269(19):13899-903. PubMed ID: 8188668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of peptide inhibitors to block type I and type III collagen-platelet interaction.
    Chiang TM
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Jun; 1(2):171-5. PubMed ID: 15320696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.